In 2019, a deadly disease referred to as coronavirus disease 2019 (COVID-19) appeared in Wuhan, China. The viral infection spread worldwide and is now a declared pandemic by the World Health Organization. Individuals living with cardiovascular disease who rely on specific treatments are a particularly vulnerable population that are more likely to suffer from severe disease and death (Tan & Aboulhosn, 2020). This deadly virus can affect the heart in different ways causing the risk of morbidity and mortality to strike for those with coronary artery disease, congestive heart failure, and hypertension (Goha, Mezue, Edwards, Nunura, Baugh, & Madu, 2020). As the number of publications increase, there is still a huge gap on the impact of COVID-19 and individuals living with cardiovascular disease. With this being said, there is a need for greater awareness of the immediate and long-term effects of COVID-19 on cardiovascular health and the significant gaps in knowledge that future research needs to address. In this review, we explore the impact of pre-existing cardiovascular diseases and the risk of mortality from COVID-19. This review summarizes key findings from the literature on the impact of COVID-19 on coronary artery disease (CAD), congestive heart failure (CHF), and hypertension (HBP).
Recommended CitationPortman, Nicole and Frasso, PhD, CPH, Rosemary, "COVID-19 and Individuals Living with Cardiovascular Disease: A Rapid Review" (2020). Master of Public Health Capstone Presentations. Presentation 364.